HD-OPM Archive
Hashtags

#davidsinclair

2 posts

First epigenetic reprogramming trial in the eye; cardiovascular use is speculative

Jun 11, 2026 · Louis Nervegna ♥ 26 · 💬 8 ↩ 1 Aging & longevity

Louis comments on the start of a clinical trial using Yamanaka-factor epigenetic reprogramming to restore youthful cell states in the eye. The eye is the testing site because it is isolated from the body by the blood-ocular barrier, limiting cancer risk. He says if it works and is safe, cardiovascular regeneration could follow, which is speculation.